Nox Medical ehf.

Nox Medical ehf specialises in devices primarily used for sleep monitoring and analysis. Their portfolio includes portable polysomnography systems like the Nox T3s System, which records and analyses sleep data. They also produce disposable and reusable electrocardiographic lead sets, nasal oxygen and pressure cannulas, scalp and cutaneous sensor kits, and software tools for interpreting sleep disorders and mental health/function screening. These devices are designed to support diagnostic and therapeutic assessments in sleep medicine.

Nox Medical ehf is based in the United States. Since they manufacture devices regulated by the FDA, their location means their products must comply with U.S. medical device regulations, including classification under FDA categories like Class I and Class II. This regulatory framework ensures their devices meet safety and performance standards before they are authorised for use in the U.S. market.

Nox Medical ehf’s devices are listed in the FDA’s 510(k) and Unique Device Identifier (UDI) registries. The 510(k) process demonstrates that their devices are substantially equivalent to legally marketed predicates, while UDI registration ensures traceability and transparency in the supply chain. Being listed in these registries confirms compliance with U.S. regulatory requirements and helps healthcare providers verify the authorised status of their products.

Nox Medical ehf’s devices are classified as either Class I or Class II under FDA regulations. Class I devices generally pose the lowest risk and are subject to general controls, while Class II devices require additional controls due to moderate risk. The classification reflects the intended use and potential risk of the device—for example, reusable lead sets or nasal cannulas may fall into Class II due to their role in critical monitoring or therapeutic applications, ensuring they undergo rigorous evaluation before authorisation.

Nox Medical ehf develops professional-only sleep disorder interpretive software and mental health/function therapeutic software viewed on-screen. These tools are designed to analyse polysomnography data and assist in diagnosing or managing sleep-related conditions. Since software in this context is classified as a medical device (especially when used for diagnostic or therapeutic purposes), it must comply with FDA regulations, including classification as Class I or Class II, depending on its risk level and intended use.